Psylocibin microdosing is the administration of
sub-perceptual quantities of psylocibin, approximately 1/10th of a hallucinatory causing dose. Early studies have shown potential for helping treat depression, reduce anxiety, reduce craving and addictive habits, increase creativity, and as more research is being conducted, more and more benefits are being discovered.
Due to the safe and sub-perceptual nature of a microdosing protocol, the patients cognitive and physical capabilities are not impaired, thus potentially allowing them to drive a car, go to work, and fulfill their daily tasks. Furthermore, this allows the patient to self-administer at home, significantly reducing the cost as compared to Macrodosing, by eliminating the need for a one-on-one setting with a therapist in a specially designed clinic, and allowing for incorporation in